Over the past few years, GLP-1 medications such as Ozempic® (semaglutide) and Mounjaro® (tirzepatide) have transformed the weight-management landscape. Patients often see dramatic improvements in appetite control and early weight loss. But here’s the challenge many physicians and patients quietly admit: 👉 What happens when the prescription ends—or when weight plateaus despite continued use? The Evidence We Need to Pay Attention To A 2022 study published in Diabetes, Obesity

The American Diabetes Association announced the findings of the comprehensive Diabetes Prevention Program. The Diabetes Prevention Program (DPP) was conducted at over 25 medical centers nationwide and involved thousands of participants who volunteered to have their habits monitored and to follow dietary and exercise recommendations. All participants had been diagnosed with 'pre-diabetes', a condition where the blood sugar levels are higher than normal, but not yet in diabeti

After this pandemic many people have taken their health into their own hands and experienced a wide range of results and others have not done much and really do not know what to do to get healthier. Internet has become a resource for everything from recipes to research giving unverified information, confusion and more Yo-Yo dieting than ever before. The truth is that NO One Size Fits All ! You are unique, you have your own preferences, your own body type, your own history a